Bioeclosion SL

BioEclosion SL is a biotechnology company founded in 2016 as a spin-off from the Universitat Autònoma de Barcelona (UAB). The company has developed a patented point-of-care in vitro diagnostic (IVD) platform that utilizes magneto-actuated biosensors to provide laboratory-grade, quantitative results in approximately ten minutes. Their technology consists of a palm-sized, battery-powered reader and single-use cartridges. When a sample is added to a cartridge, an internal magnet concentrates magnetic micro-particles on a screen-printed electrode, and the electrochemical signal is processed and displayed directly on a smartphone or tablet. The platform is designed to be agnostic, allowing the same reader to be used across diverse assays by simply changing the cartridge, with capabilities for both protein or viral targets and DNA or RNA detection via on-cartridge isothermal amplification.

This diagnostic solution is intended for use in resource-limited settings or environments where specialized equipment, cold chain logistics, or specialized personnel are unavailable. The company applies its technology across human health, veterinary medicine, food safety, and environmental monitoring, with specific programs addressing conditions such as coeliac disease, group B streptococcal sepsis, and avian influenza. By providing rapid, high-precision diagnostics, BioEclosion aims to improve patient triage, support antibiotic stewardship, and facilitate immediate biosecurity actions in agricultural and clinical settings. The company's development work is supported by international patents and European research consortia.